BAKER BROS. ADVISORS LP 13D and 13G filings for Achilles Therapeutics plc:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-14 4:23 pm Sale | 2024-09-30 | 13G | Achilles Therapeutics plc ACHL | BAKER BROS. ADVISORS LP | 0 0.000% | -3,311,567 (Position Closed) | Filing |
| 2024-02-14 4:21 pm Sale | 2023-12-31 | 13G | Achilles Therapeutics plc ACHL | BAKER BROS. ADVISORS LP | 3,311,567 8.100% | -896,166 (-21.30%) | Filing |
| 2023-02-14 4:00 pm Purchase | 2022-12-31 | 13G | Achilles Therapeutics plc ACHL | BAKER BROS. ADVISORS LP | 4,207,733 9.900% | 168,253 (+4.17%) | Filing |
| 2022-02-14 4:12 pm Purchase | 2021-12-31 | 13G | Achilles Therapeutics plc ACHL | BAKER BROS. ADVISORS LP | 4,039,480 9.990% | 4,039,480 (New Position) | Filing |